Newborn screening is essential to improve diagnosis and outcomes

Maintaining the voice of rare diseases in a new, virtual world: Insights from the European Conference on Rare Diseases (ECRD) 2020

Newborn screening is essential to improve diagnosis and outcomes

Alpharmaxim work closely with industry to provide education around newborn screening and can help to drive awareness of newborn screening panels. It is important to increase the number of newborn screening panels and harmonise their number and size across Europe. Newborn screening:

  • Allows for early diagnosis and, therefore, management of rare genetic diseases
  • Could have a significant impact on the burden on healthcare systems and patients/families
  • Could lead to a reduction in later misdiagnosis and suffering

Be prepared to truly demonstrate your commitment to the rare disease field, particularly in these uncertain times.

Talk to us about how we can transform your communications

Alpharmaxim in the press

Alpharmaxim in the press

With many organisations beginning to invest in behavioural science, we’ve been shouting in the press about the benefits for pharma companies.
Ten ways that internal communications can boost your business

Ten ways that internal communications can boost your business

Employee engagement, brand alignment, sharing expertise to solve problems: these are all things that internal communications can achieve.
It's time for behavioural science to take centre stage in health communications

It's time for behavioural science to take centre stage in health communications

Progress brings new challenges, and help is needed. It might be time for behavioural science to play a bigger part than ever before.